Immatics (IMTX) Interest Income - Deposits (2019 - 2025)
Immatics (IMTX) posted Interest Income - Deposits of $5.0 million for Q4 2025, down 6.71% sequentially from $5.3 million in Q3 2025, and up 2.94% YoY from $4.8 million in Q4 2024.
Immatics (IMTX) Interest Income - Deposits (2019 - 2025) Analysis & Trends
Immatics has reported Interest Income - Deposits for 7 years, with the latest figure at $5.0 million in Q4 2025.
- Quarterly Interest Income - Deposits rose 2.94% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.5 million (up 74.98% YoY) and the FY2025 annual result came in at $30.3 million, up 79.39% from the prior year.
- Interest Income - Deposits slipped to $5.0 million in Q4 2025 per IMTX's latest filing, from $5.3 million in the prior quarter.
- Over five years, Interest Income - Deposits peaked at $15.4 million in Q1 2025 and troughed at -$5.3 million in Q4 2023.
- A 5-year average of $3.6 million and a median of $3.1 million in 2023 frame the typical range for Interest Income - Deposits.
- The sharpest annual moves came in 2022 and 2023: Interest Income - Deposits jumped 4031.27% in 2022, then plunged 459.4% in 2023.
- Over 5 years, Interest Income - Deposits stood at $35463.1 in 2021, then jumped by 4031.27% to $1.5 million in 2022, then slumped by 459.4% to -$5.3 million in 2023, then jumped by 191.47% to $4.8 million in 2024, then gained by 2.94% to $5.0 million in 2025.
- According to Business Quant data, Interest Income - Deposits over the past three periods registered $5.0 million, $5.3 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Deposits (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 4.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 5.31 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 15.43 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 6.22 Mn |
| Mar 31, 2024 | 2.70 Mn |
| Dec 31, 2023 | -5.27 Mn |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 938,652.83 |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 7.90 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 35,463.10 |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 256,509.82 |
| Mar 31, 2021 | 4.18 Mn |